Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Josh C. Pleasure, M.D. who wrote (68)	12/14/1996 2:53:00 PM
From: M. LaMancha	of 371

Dr. Pleasure -- sorry to put you on the spot about your source of the buyout rumor. This has been kicking around for a while and was hoping to nail down a specific. From your posts, I am guessing you are a radiologist specializing in nuclear medicine. I would very much appreciate your reaction on three points. First, CEA-Scan is going for I beleive $350 a dose. Is that accurate or is the cost higher? Second, I would appreciate your opinion on whether this cost is a barrier to its widespread use, meaning use outside top cancer centers. Also, given your apparent expertise in nuclear medicine, what if any, is your impression of Prostascint by Cytogen. The product is selling for I beleive $700 per doseand the estimates I am hearing on another thread for revenues coming into Cytogen seem overly optimistic.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next